35 related articles for article (PubMed ID: 9186541)
1. Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease.
Ngoma T; Adde M; Durosinmi M; Githang'a J; Aken'Ova Y; Kaijage J; Adeodou O; Rajab J; Brown BJ; Leoncini L; Naresh K; Raphael M; Hurwitz N; Scanlan P; Rohatiner A; Venzon D; Magrath I
Br J Haematol; 2012 Sep; 158(6):749-62. PubMed ID: 22844968
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of moderate dose combination chemotherapy in Burkitt's lymphoma.
Patel JG; Pandita R; al-Jazzaf H; Mechl Z; al-Jarallah MA
Neoplasma; 1993; 40(3):185-8. PubMed ID: 8350967
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
[TBL] [Abstract][Full Text] [Related]
4. Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children.
Spreafico F; Massimino M; Luksch R; Casanova M; Cefalo GS; Collini P; Ferrari A; Polastri D; Terenziani M; Gasparini M; Fossati-Bellani F
J Clin Oncol; 2002 Jun; 20(12):2783-8. PubMed ID: 12065554
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.
Kojima Y; Hagiwara S; Uehira T; Ajisawa A; Kitanaka A; Tanuma J; Okada S; Nagai H
Jpn J Clin Oncol; 2014 Apr; 44(4):318-23. PubMed ID: 24558129
[TBL] [Abstract][Full Text] [Related]
6. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Reiter A; Schrappe M; Tiemann M; Ludwig WD; Yakisan E; Zimmermann M; Mann G; Chott A; Ebell W; Klingebiel T; Graf N; Kremens B; Müller-Weihrich S; Plüss HJ; Zintl F; Henze G; Riehm H
Blood; 1999 Nov; 94(10):3294-306. PubMed ID: 10552938
[TBL] [Abstract][Full Text] [Related]
7. Severe central nervous adverse effect of intrathecal chemotherapy in a 16-yr-old patient with Burkitt's type lymphoma.
Geissler RG; Bergmann L; Hacker H; Knupp B; Walker B; Hoelzer D
Eur J Haematol; 1997 Apr; 58(4):286-8. PubMed ID: 9186541
[No Abstract] [Full Text] [Related]
8. Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial).
Xicoy B; Ribera JM; Esteve J; Brunet S; Sanz MA; Fernández-Abellán P; Feliu E
Leuk Lymphoma; 2003 Sep; 44(9):1541-3. PubMed ID: 14565657
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of Burkitt lymphoma and Burkitt-like lymphoma].
Maruyama D
Rinsho Ketsueki; 2011 Oct; 52(10):1645-54. PubMed ID: 21971242
[No Abstract] [Full Text] [Related]
10. Non-hodgkins lymphoma.
Mead G; Woodcock J; Young C
Clin Evid; 2003 Jun; (9):1-21. PubMed ID: 12967352
[No Abstract] [Full Text] [Related]
11. [Treatment strategy of gray zone lymphomas].
Maruyama D
Rinsho Ketsueki; 2014 Oct; 55(10):1912-9. PubMed ID: 25297755
[No Abstract] [Full Text] [Related]
12. Excessive spinal cord toxicity from intensive central nervous system-directed therapies.
Watterson J; Toogood I; Nieder M; Morse M; Frierdich S; Lee Y; Moertel CL; Priest JR
Cancer; 1994 Dec; 74(11):3034-41. PubMed ID: 7954266
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
